Product Information
ZIDOVUDINE 300 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.4016 per EA under NDC 65862002460. Its NADAC has been published 492 times since Nov 28, 2013.
FDA first approved this application on Sep 19, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862002460
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
ZIDOVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA077267FDA Approved
9/19/2005
TE Code
AB
On Market Since
9/19/2005
Pharmacological Classes
Price Statistics
The NADAC for ZIDOVUDINE 300 MG TABLET has been published 492 times since Nov 28, 2013, and over the history we have for it it has risen 35.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4016 per EA |
|---|---|
| All-time high | $0.4991 (Dec 15, 2021) |
| All-time low | $0.2729 (Apr 23, 2014) |
| Median price | $0.3973 |
| Average price | $0.3927 |
| Largest weekly change | +41.0% (Dec 21, 2016) |
| Weeks tracked | 492 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-19.5%
5Y
-19.5%
All
+35.0%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZIDOVUDINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZIDOVUDINE 300 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.4016 per EA (NDC 65862002460), effective Aug 20, 2025.
How has the price of ZIDOVUDINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZIDOVUDINE 300 MG TABLET has risen 35.0%. It has been tracked across 492 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZIDOVUDINE 300 MG TABLET?
Since Nov 28, 2013, the NADAC for ZIDOVUDINE 300 MG TABLET has ranged from a low of $0.2729 (Apr 23, 2014) to a high of $0.4991 (Dec 15, 2021), with a median of $0.3973 per EA.
Are there cheaper alternatives to ZIDOVUDINE 300 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ZIDOVUDINE 300 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ZIDOVUDINE 300 MG TABLET?
ZIDOVUDINE 300 MG TABLET (NDC 65862002460) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.